Pepper Huang

We analyze hospital price transparency data to show variations in reimbursement for autoimmune drugs, with implications for patient access and affordability.

We discuss five key considerations for manufacturers negotiating Medicare Part D formulary access in the wake of the Inflation Reduction Act.

For some people with diabetes, hypertension, or hyperlipidemia, there’s a stronger relationship between medication adherence and lower healthcare costs for patients with high risk scores.